Trial intelligence / Profile preview

Elemene plus Stupp Protocol in newly-diagnosed glioblastoma

NCT05842746Phase 2Not yet recruiting

Sponsor
Peking Union Medical College Hospital
Start
May 2023
Primary completion
Dec 2026
Modality
Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Elemene in glioblastoma (GBM), sponsored by Peking Union Medical College Hospital. Planned start May 2023; status: not yet recruiting.

02

Drugs

Elemene
03

Conditions

glioblastoma (GBM)

Beyond the preview

Go deeper on NCT05842746.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05842746.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call